News and Announcements
ASMX, the tech company using blockchain to evolve P2P lending
- Published October 30, 2018 12:00AM UTC
- Publisher Wholesale Investor
- Categories Company Updates
KEY TAKEAWAYS:
- ASMX is working with Ablrate, a UK based asset-backed Peer to Peer (P2P) lending platform.
- Their blockchain technology will be integrated into new and existing online debt platforms.
- Blockchain technology is a digital tool enabling transactions in cryptocurrency.
ASMX is evolving Peer to Peer (P2P) lending by introducing a blockchain based solution to enable global trade.
ASMX’s technology will be integrated into new and existing online debt platforms.
ASMX is working with Ablrate, a UK based asset-backed Peer to Peer (P2P) lending platform, in a bid to enhance their worldwide reach and connect lenders and borrowers.
The company aims to connect and enhance trading and online lending ecosystems.
A unique feature to the online lending industry, ASMX will utilise Distributed Ledger Technology (DLT), tokenisation and smart contracts to facilitate P2P trading of private debt between separate platforms, internationally.
David Bradley-Ward, ASMX CEO, said: “We are extremely thrilled to be working towards this next stage in P2P lending, and our existing users are ready to embrace a new tool that will give them more choice and allow more sophisticated management of their lending.”
To find out more, check out ASMX’s Press Pack HERE.
About ASMX Ltd
P2P lending has become a large business in a very short space of time, and is set to continue its growth. However, the successful scaling of any market is ‘Access’ and ‘Liquidity’.
ASMX will provide a decentralised blockchain based solution for trading private debt originated by existing and an expanding online lending network that will be accessible to qualifying retail lenders globally.
Company Updates
500 Million Episodes, Limited Treatment: How Patrys is Bridging the Gap in an Underserved Market
In the clinical vocabulary of the Intensive Care Unit, there is perhaps no word that carries as much quiet dread as delirium. It is a “chemical storm” of the brain—an acute dysfunction where the delicate balance between calming and activating signals is scrambled. For the patient, it can be a waking nightmare of hallucinations and […]
The Light Fantastic: Why Invion’s Photodynamic Therapy May Be Attracting Big Pharma’s Attention
Invion Limited is challenging the status quo in oncology with its Photosoft™ platform, a precision therapy that uses light-activated molecules to selectively target cancer cells. By transforming the body’s own immune response and addressing the high costs of current cancer treatments, Invion is positioning itself as a transformative player in the biotech sector. With clinical trials underway and strong institutional partnerships, the company is bridging the gap between scientific breakthrough and accessible, scalable patient care.
From Outback to Boardroom: How SWAN Systems is Codifying Water Stewardship
From the arid deserts of Australia to the boardrooms of global tech giants, SWAN Systems is redefining water efficiency. By bridging the gap between field-level agronomics and autonomous irrigation control, the company is proving that “water-positive” targets can be met with science, data, and a 10x ROI commitment.
Backed By Leading Investment Groups and Family Offices
